A pharmacoeconomic study of pegaspargase in the treatment of pediatric acute lymphoblastic leukemia in Russia

N. А. Avxentyev(The Russian Presidential Academy of National Economy and Public Administration), Р. А. Зинченко, Yu. A. Shifrin(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), M. Yu. Frolov(Volgograd State Medical University), G. А. Novichkova(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), С. А. Демура, A. I. Karachunskiy(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), A. S. Makarov, Yu. V. Rumyantseva(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology)
Pediatric Hematology/Oncology and Immunopathology
December 26, 2022
10.24287/1726-1708-2022-21-4-60-69
Cited by 3

Related Papers

Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13
Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model
|Biochemical and Biophysical Research Communications|2025|12